This notice is for prior information only
Legal Basis:
Regulation (EU, Euratom) No 2018/1046
Section I: Contracting authority
I.3)CommunicationAdditional information can be obtained from the abovementioned address
I.4)Type of the contracting authorityEuropean institution/agency or international organisation
I.5)Main activityGeneral public services
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
Investigating in Vitro Tools for the Toxicological Evaluation of Proteins in Food and Feed Risk Assessment
Reference number: OC/EFSA/GMO/2021/03
II.1.2)Main CPV code73200000 Research and development consultancy services
II.1.3)Type of contractServices
II.1.4)Short description:
Protein toxicity can be due to various mechanisms of action at molecular level (e.g. ion channel inhibitor activity, metal ion binding, etc), or be associated to biological processes (e.g. hemolysis, lipid catabolic process, defence response) and/or on the basis of the cellular component affected (Palazzolo et al. 2020). Proteins under assessment can be tested using in vitro systems, this efficiently integrating in silico predictions. The target of this work is to gather information on the available in vitro systems used to test the above toxicity mechanisms, processes or relevant cellular components and to evaluate their applicability to testing protein toxicity. Following the identification of in vitro tools, testing strategies for selected toxic proteins (i.e. identification of fit-for purpose battery of in vitro tools for a selection of toxic proteins) should also be developed.
II.1.5)Estimated total valueValue excluding VAT: 150 000.00 EUR
II.1.6)Information about lotsThis contract is divided into lots: no
II.2)Description
II.2.3)Place of performanceNUTS code: ITH52 Parma
II.2.4)Description of the procurement:
Protein toxicity can be due to various mechanisms of action at molecular level (e.g. ion channel inhibitor activity, metal ion binding, etc), or be associated to biological processes (e.g. hemolysis, lipid catabolic process, defence response) and/or on the basis of the cellular component affected (Palazzolo et al. 2020). Proteins under assessment can be tested using in vitro systems, this efficiently integrating in silico predictions. The target of this work is to gather information on the available in vitro systems used to test the above toxicity mechanisms, processes or relevant cellular components and to evaluate their applicability to testing protein toxicity. Following the identification of in vitro tools, testing strategies for selected toxic proteins (i.e. identification of fit-for purpose battery of in vitro tools for a selection of toxic proteins) should also be developed.
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:30/06/2021
Section IV: Procedure
IV.1)Description
IV.1.8)Information about the Government Procurement Agreement (GPA)The procurement is covered by the Government Procurement Agreement: no
Section VI: Complementary information
VI.3)Additional information:
VI.5)Date of dispatch of this notice:12/05/2021